Patents by Inventor Spiros Liras

Spiros Liras has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 3,3-Biarylpiperidine and 2,2-biarylmorpholine derivatives
    Patent number: 6586431
    Abstract: The present invention relates to compounds of the formula I, wherein Z1, Z2, X, Q, R1, R2 and R3 are defined as in the specification, pharmaceutical compositions containing such compounds the use of such compounds to treat neurological and gastrointestinal disorders.
    Type: Grant
    Filed: May 31, 2000
    Date of Patent: July 1, 2003
    Assignee: Pfizer Inc
    Inventors: Spiros Liras, Martin P. Allen, Barbara E. Segelstein
  • 3-azabicyclo[3.1.0]hexane derivatives
    Publication number: 20030087898
    Abstract: The subject invention provides a compound of the formula 1, 1
    Type: Application
    Filed: October 22, 2002
    Publication date: May 8, 2003
    Applicant: Pfizer Inc.
    Inventors: Stanton F. McHardy, Spiros Liras, Steven D. Heck
  • Benzimidazole and pyridylimidazole derivatives
    Publication number: 20030069257
    Abstract: This invention relates to benzimidazoles, pyridylimidazoles and related bicyclic heteroaryl compounds, all of which may be described by of Formula I 1
    Type: Application
    Filed: December 21, 2001
    Publication date: April 10, 2003
    Inventors: Guiying Li, John M. Peterson, Pamela Albaugh, Kevin S. Currie, Guolin Cai, Linda M. Gustavson, Kyungae Lee, Alan Hutchison, Vinod Singh, George D. Maynard, Jun Yuan, Ling Hong Xie, Manuka Ghosh, Nian Liu, George P. Luke, Scott Mitchell, Martin Patrick Allen, Spiros Liras
  • 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
    Patent number: 6503905
    Abstract: The present invention relates to compounds of the formula I, wherein Z1, Z2, X, Q, R1, R2 and R3 are defined as in the specification, pharmaceutical compositions containing such compounds the use of such compounds to treat neurological and gastrointestinal disorders.
    Type: Grant
    Filed: August 6, 1999
    Date of Patent: January 7, 2003
    Assignee: Pfizer Inc
    Inventors: Spiros Liras, Martin P. Allen, Barbara E. Segelstein
  • 4-phenyl-4-heteroarylpiperidine derivatives
    Patent number: 6444679
    Abstract: The present invention relates to compounds of the formula I, wherein Z1, X, Y, ( )n, R1, R2 and R3 are defined as in the specification, pharmaceutical compositions containing such compounds; and the use of such compounds to treat neurological and gastrointestinal disorders.
    Type: Grant
    Filed: February 14, 2000
    Date of Patent: September 3, 2002
    Assignee: Pfizer Inc
    Inventors: Spiros Liras, Stanton F. McHardy
  • Use of delta opioid receptor ligands and serotonin reuptake inhibitors in the treatment of chemical dependencies
    Publication number: 20020077323
    Abstract: A method for treating a chemical dependency that involves administering an amount of a delta opioid receptor ligand and a serotonin reuptake inhibitor, the amounts being effective in the combination to treat the dependency, wherein the delta opioid receptor ligand is selected from the group consisting of:
    Type: Application
    Filed: July 9, 2001
    Publication date: June 20, 2002
    Inventors: Stafford McLean, Spiros Liras, Stanton F. Mchardy
  • 4,4-Biarylpiperidine derivatives
    Publication number: 20020013321
    Abstract: The present invention relates to compounds of the formula I, 1
    Type: Application
    Filed: July 10, 2001
    Publication date: January 31, 2002
    Inventor: Spiros Liras